+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
4-AA for Carbapenem Antibiotic Market - Global Forecast 2026-2032- Product Image
4-AA for Carbapenem Antibiotic Market - Global Forecast 2026-2032- Product Image
New

4-AA for Carbapenem Antibiotic Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 193 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6125508
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The 4-AA for Carbapenem Antibiotic Market is transforming as healthcare systems adapt to new stewardship priorities, procurement demands, and evolving regulatory landscapes. Senior executives must navigate dynamic operational risks and opportunities to achieve resilience and growth in this complex marketplace.

Market Snapshot: 4-AA for Carbapenem Antibiotic Market

The 4-AA for Carbapenem Antibiotic Market advanced from USD 93.76 million in 2025 to USD 107.14 million in 2026 and is forecasted to reach USD 162.54 million by 2032, demonstrating an anticipated CAGR of 8.17%. This sustained expansion is driven by consistent demand for last-line antibiotic therapies, reinforced stewardship controls, and the rising imperative to counter antimicrobial resistance. Across the healthcare and pharmaceutical sectors, strategic procurement, resilient supply networks, and mindful stewardship guide value creation and operational priorities.

Scope & Segmentation

This report delivers a detailed examination of the 4-AA carbapenem antibiotic market, offering comprehensive insights to support strategic planning and informed decision-making:

  • Therapeutic Application Areas: Includes severe and complex infection cases such as intra-abdominal infections, hospital-acquired and ventilator-associated pneumonia, complicated urinary tract infections, bacteremia, and sepsis.
  • Drug Form and Administration Route: Focused on intravenous formulations tailored for inpatient care, with attention to dosing for renally impaired individuals and workflow optimization in clinical settings.
  • End-User Settings: Encompasses large tertiary hospitals, community healthcare institutions, specialized centers, and long-term acute care facilities, each presenting unique utilization and stewardship requirements.
  • Distribution Channels: Hospital pharmacies, specialty medical distributors, and wholesalers—along with their varying expectations for supply reliability and fulfillment speed—are analyzed to illustrate supply chain dynamics.
  • Regional Coverage: Robust analysis across the Americas, Europe, Middle East & Africa, and Asia-Pacific reflects regional differences in stewardship practices, diagnostic accessibility, and procurement mechanisms.
  • Technology Innovations: Explores the impact of rapid diagnostics, advances in molecular and syndromic testing, and the integration of data-driven stewardship solutions in clinical and supply environments.

Key Takeaways for Senior Decision-Makers

  • Antimicrobial stewardship maturity actively influences prescriber behavior, shaping when and how 4-AA carbapenem products are introduced into standard therapeutic algorithms across healthcare institutions.
  • Rapid diagnostic tools and integrated data systems enable targeted therapy in defined patient groups, supporting precise intervention and streamlined workflow at the clinical frontline.
  • Supply chain resilience and continuous manufacturing capability are emerging as critical selection criteria, as stakeholders seek reliability and consistency to support critical care.
  • Operational fit remains paramount—products must support efficient administration, adapt to evolving protocols, and reinforce stewardship checkpoints to ensure compliance and value delivery.
  • Regional market outcomes are significantly influenced by variations in procurement structures, stewardship enforcement, and advanced diagnostic infrastructure, creating both obstacles and opportunities worldwide.
  • Adoption of combination therapies, optimization of dosing regimens, and the introduction of value-based contracting methods help differentiate solutions within increasingly stringent stewardship frameworks.

Tariff Impact on Supply Chains and Operations

Prospective changes to U.S. tariffs in 2025 generate significant uncertainty for the antibiotic supply chain, especially for products dependent on globally sourced active pharmaceutical ingredients and complex raw materials. Immediate procurement and contracting approaches may shift as buyers look to address price instability and maintain steady access. Suppliers are implementing measures such as dual sourcing, expanding domestic production, and introducing flexible contracts to mitigate risk. However, these economic trends may challenge smaller market participants. Hospitals are likely to prioritize products with stable availability and manageable costs for essential care, reinforcing the urgency of proactive risk management throughout the supply chain.

Methodology & Data Sources

This market intelligence report integrates targeted secondary research with primary interviews, engaging regulatory, clinical, and supply chain perspectives. Findings have undergone rigorous data triangulation for analytical consistency and are validated across stakeholder domains, encompassing practice trends, procurement workflows, and innovation adoption patterns.

Why This Report Matters

  • Empowers senior leaders to proactively address shifting procurement challenges, emerging stewardship directives, and regional disparities, thereby enhancing strategic positioning in the carbapenem antibiotic sector.
  • Delivers practical insights into the convergence of clinical, operational, and supply-side forces, underpinning supply reliability, access planning, and the sustainability of market strategies.
  • Enables robust organizational planning in contexts affected by economic disruption and evolving national policies impacting critical care supply chains.

Conclusion

The 4-AA carbapenem antibiotic market is shaped by a disciplined approach to stewardship, rapid diagnostic innovation, and a fundamental need for consistent supply. Organizations that align strategically with these factors will uphold reliability and meet evolving care standards.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. 4-AA for Carbapenem Antibiotic Market, by Molecule
8.1. Biapenem
8.2. Doripenem
8.3. Ertapenem
8.4. Imipenem
8.5. Meropenem
8.6. Panipenem
9. 4-AA for Carbapenem Antibiotic Market, by Dosage Form
9.1. Capsule
9.2. Injection Solution
9.2.1. Ampoule
9.2.2. Vial
9.3. Powder For Injection
9.3.1. Pre-Filled Syringe
9.3.2. Vial
9.4. Tablet
10. 4-AA for Carbapenem Antibiotic Market, by Route
10.1. Intravenous
10.2. Oral
11. 4-AA for Carbapenem Antibiotic Market, by Indication
11.1. Bacterial Sepsis
11.2. Complicated Intra-Abdominal Infection
11.3. Complicated Urinary Tract Infection
11.4. Hospital-Acquired Pneumonia
12. 4-AA for Carbapenem Antibiotic Market, by Distribution Channel
12.1. Direct Tender
12.1.1. Government Tender
12.1.2. Private Tender
12.2. Hospital Pharmacies
12.2.1. Private Hospital Pharmacies
12.2.2. Public Hospital Pharmacies
12.3. Online Pharmacies
12.3.1. Manufacturer Owned Platforms
12.3.2. Third Party Platforms
12.4. Retail Pharmacies
12.4.1. Chain Pharmacies
12.4.2. Independent Pharmacies
13. 4-AA for Carbapenem Antibiotic Market, by End User
13.1. Ambulatory Surgical Center
13.1.1. Multi Specialty
13.1.2. Single Specialty
13.2. Clinic
13.2.1. General Clinic
13.2.2. Specialty Clinic
13.3. Hospital
13.3.1. Private Hospital
13.3.2. Public Hospital
14. 4-AA for Carbapenem Antibiotic Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. 4-AA for Carbapenem Antibiotic Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. 4-AA for Carbapenem Antibiotic Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States 4-AA for Carbapenem Antibiotic Market
18. China 4-AA for Carbapenem Antibiotic Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. AstraZeneca plc
19.6. Asymchem Laboratories (Tianjin) Co., Ltd.
19.7. Aurobindo Pharma Ltd.
19.8. Daewoong Pharmaceutical Co., Ltd.
19.9. Dr. Reddy's Laboratories Ltd.
19.10. Eli Lilly and Company
19.11. Fresenius Kabi AG
19.12. Gland Pharma Limited
19.13. GlaxoSmithKline plc
19.14. Hikma Pharmaceuticals PLC
19.15. Lupin Limited
19.16. Merck & Co., Inc.
19.17. Pfizer Inc.
19.18. Sandoz AG
19.19. Shionogi & Co., Ltd.
19.20. Sun Pharmaceutical Industries Ltd.
19.21. Teva Pharmaceutical Industries Ltd.
List of Figures
FIGURE 1. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY MOLECULE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY ROUTE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY MOLECULE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY BIAPENEM, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY BIAPENEM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY BIAPENEM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DORIPENEM, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DORIPENEM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DORIPENEM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY ERTAPENEM, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY ERTAPENEM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY ERTAPENEM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY IMIPENEM, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY IMIPENEM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY IMIPENEM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY MEROPENEM, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY MEROPENEM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY MEROPENEM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY PANIPENEM, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY PANIPENEM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY PANIPENEM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY CAPSULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY INJECTION SOLUTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY INJECTION SOLUTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY INJECTION SOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY INJECTION SOLUTION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY AMPOULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY AMPOULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY AMPOULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY VIAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY VIAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY VIAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY POWDER FOR INJECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY POWDER FOR INJECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY POWDER FOR INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY POWDER FOR INJECTION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY PRE-FILLED SYRINGE, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY PRE-FILLED SYRINGE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY PRE-FILLED SYRINGE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY VIAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY VIAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY VIAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY ROUTE, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY BACTERIAL SEPSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY BACTERIAL SEPSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY BACTERIAL SEPSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY COMPLICATED INTRA-ABDOMINAL INFECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY COMPLICATED INTRA-ABDOMINAL INFECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY COMPLICATED INTRA-ABDOMINAL INFECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY COMPLICATED URINARY TRACT INFECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY COMPLICATED URINARY TRACT INFECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY COMPLICATED URINARY TRACT INFECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY HOSPITAL-ACQUIRED PNEUMONIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY HOSPITAL-ACQUIRED PNEUMONIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY HOSPITAL-ACQUIRED PNEUMONIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DIRECT TENDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DIRECT TENDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DIRECT TENDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DIRECT TENDER, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY GOVERNMENT TENDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY GOVERNMENT TENDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY GOVERNMENT TENDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY PRIVATE TENDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY PRIVATE TENDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY PRIVATE TENDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY PRIVATE HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY PRIVATE HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY PRIVATE HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY PUBLIC HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY PUBLIC HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY PUBLIC HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY MANUFACTURER OWNED PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY MANUFACTURER OWNED PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY MANUFACTURER OWNED PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY THIRD PARTY PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY THIRD PARTY PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY THIRD PARTY PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY CHAIN PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY CHAIN PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY INDEPENDENT PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY INDEPENDENT PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY MULTI SPECIALTY, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY MULTI SPECIALTY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY MULTI SPECIALTY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY SINGLE SPECIALTY, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY SINGLE SPECIALTY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY SINGLE SPECIALTY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY CLINIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY GENERAL CLINIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY GENERAL CLINIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY GENERAL CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY PUBLIC HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY PUBLIC HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 141. AMERICAS 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 142. AMERICAS 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY MOLECULE, 2018-2032 (USD MILLION)
TABLE 143. AMERICAS 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 144. AMERICAS 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY INJECTION SOLUTION, 2018-2032 (USD MILLION)
TABLE 145. AMERICAS 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY POWDER FOR INJECTION, 2018-2032 (USD MILLION)
TABLE 146. AMERICAS 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY ROUTE, 2018-2032 (USD MILLION)
TABLE 147. AMERICAS 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 148. AMERICAS 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 149. AMERICAS 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DIRECT TENDER, 2018-2032 (USD MILLION)
TABLE 150. AMERICAS 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 151. AMERICAS 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 152. AMERICAS 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 153. AMERICAS 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 154. AMERICAS 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
TABLE 155. AMERICAS 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
TABLE 156. AMERICAS 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
TABLE 157. NORTH AMERICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 158. NORTH AMERICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY MOLECULE, 2018-2032 (USD MILLION)
TABLE 159. NORTH AMERICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 160. NORTH AMERICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY INJECTION SOLUTION, 2018-2032 (USD MILLION)
TABLE 161. NORTH AMERICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY POWDER FOR INJECTION, 2018-2032 (USD MILLION)
TABLE 162. NORTH AMERICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY ROUTE, 2018-2032 (USD MILLION)
TABLE 163. NORTH AMERICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 164. NORTH AMERICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 165. NORTH AMERICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DIRECT TENDER, 2018-2032 (USD MILLION)
TABLE 166. NORTH AMERICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 167. NORTH AMERICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 168. NORTH AMERICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 169. NORTH AMERICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. NORTH AMERICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
TABLE 171. NORTH AMERICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
TABLE 172. NORTH AMERICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
TABLE 173. LATIN AMERICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. LATIN AMERICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY MOLECULE, 2018-2032 (USD MILLION)
TABLE 175. LATIN AMERICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 176. LATIN AMERICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY INJECTION SOLUTION, 2018-2032 (USD MILLION)
TABLE 177. LATIN AMERICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY POWDER FOR INJECTION, 2018-2032 (USD MILLION)
TABLE 178. LATIN AMERICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY ROUTE, 2018-2032 (USD MILLION)
TABLE 179. LATIN AMERICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 180. LATIN AMERICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 181. LATIN AMERICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DIRECT TENDER, 2018-2032 (USD MILLION)
TABLE 182. LATIN AMERICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 183. LATIN AMERICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 184. LATIN AMERICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 185. LATIN AMERICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 186. LATIN AMERICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
TABLE 187. LATIN AMERICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
TABLE 188. LATIN AMERICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY MOLECULE, 2018-2032 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY INJECTION SOLUTION, 2018-2032 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY POWDER FOR INJECTION, 2018-2032 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY ROUTE, 2018-2032 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DIRECT TENDER, 2018-2032 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
TABLE 205. EUROPE 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 206. EUROPE 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY MOLECULE, 2018-2032 (USD MILLION)
TABLE 207. EUROPE 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 208. EUROPE 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY INJECTION SOLUTION, 2018-2032 (USD MILLION)
TABLE 209. EUROPE 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY POWDER FOR INJECTION, 2018-2032 (USD MILLION)
TABLE 210. EUROPE 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY ROUTE, 2018-2032 (USD MILLION)
TABLE 211. EUROPE 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 212. EUROPE 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 213. EUROPE 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DIRECT TENDER, 2018-2032 (USD MILLION)
TABLE 214. EUROPE 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 215. EUROPE 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 216. EUROPE 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 217. EUROPE 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 218. EUROPE 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
TABLE 219. EUROPE 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
TABLE 220. EUROPE 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
TABLE 221. MIDDLE EAST 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 222. MIDDLE EAST 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY MOLECULE, 2018-2032 (USD MILLION)
TABLE 223. MIDDLE EAST 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 224. MIDDLE EAST 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY INJECTION SOLUTION, 2018-2032 (USD MILLION)
TABLE 225. MIDDLE EAST 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY POWDER FOR INJECTION, 2018-2032 (USD MILLION)
TABLE 226. MIDDLE EAST 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY ROUTE, 2018-2032 (USD MILLION)
TABLE 227. MIDDLE EAST 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 228. MIDDLE EAST 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 229. MIDDLE EAST 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DIRECT TENDER, 2018-2032 (USD MILLION)
TABLE 230. MIDDLE EAST 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 231. MIDDLE EAST 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 232. MIDDLE EAST 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 233. MIDDLE EAST 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 234. MIDDLE EAST 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
TABLE 235. MIDDLE EAST 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
TABLE 236. MIDDLE EAST 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
TABLE 237. AFRICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 238. AFRICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY MOLECULE, 2018-2032 (USD MILLION)
TABLE 239. AFRICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 240. AFRICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY INJECTION SOLUTION, 2018-2032 (USD MILLION)
TABLE 241. AFRICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY POWDER FOR INJECTION, 2018-2032 (USD MILLION)
TABLE 242. AFRICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY ROUTE, 2018-2032 (USD MILLION)
TABLE 243. AFRICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 244. AFRICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 245. AFRICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DIRECT TENDER, 2018-2032 (USD MILLION)
TABLE 246. AFRICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 247. AFRICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 248. AFRICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 249. AFRICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 250. AFRICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
TABLE 251. AFRICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
TABLE 252. AFRICA 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
TABLE 253. ASIA-PACIFIC 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 254. ASIA-PACIFIC 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY MOLECULE, 2018-2032 (USD MILLION)
TABLE 255. ASIA-PACIFIC 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 256. ASIA-PACIFIC 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY INJECTION SOLUTION, 2018-2032 (USD MILLION)
TABLE 257. ASIA-PACIFIC 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY POWDER FOR INJECTION, 2018-2032 (USD MILLION)
TABLE 258. ASIA-PACIFIC 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY ROUTE, 2018-2032 (USD MILLION)
TABLE 259. ASIA-PACIFIC 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 260. ASIA-PACIFIC 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 261. ASIA-PACIFIC 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DIRECT TENDER, 2018-2032 (USD MILLION)
TABLE 262. ASIA-PACIFIC 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 263. ASIA-PACIFIC 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 264. ASIA-PACIFIC 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 265. ASIA-PACIFIC 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 266. ASIA-PACIFIC 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
TABLE 267. ASIA-PACIFIC 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
TABLE 268. ASIA-PACIFIC 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
TABLE 269. GLOBAL 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 270. ASEAN 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 271. ASEAN 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY MOLECULE, 2018-2032 (USD MILLION)
TABLE 272. ASEAN 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 273. ASEAN 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY INJECTION SOLUTION, 2018-2032 (USD MILLION)
TABLE 274. ASEAN 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY POWDER FOR INJECTION, 2018-2032 (USD MILLION)
TABLE 275. ASEAN 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY ROUTE, 2018-2032 (USD MILLION)
TABLE 276. ASEAN 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 277. ASEAN 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 278. ASEAN 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DIRECT TENDER, 2018-2032 (USD MILLION)
TABLE 279. ASEAN 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 280. ASEAN 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 281. ASEAN 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 282. ASEAN 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 283. ASEAN 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
TABLE 284. ASEAN 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
TABLE 285. ASEAN 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
TABLE 286. GCC 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 287. GCC 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY MOLECULE, 2018-2032 (USD MILLION)
TABLE 288. GCC 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 289. GCC 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY INJECTION SOLUTION, 2018-2032 (USD MILLION)
TABLE 290. GCC 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY POWDER FOR INJECTION, 2018-2032 (USD MILLION)
TABLE 291. GCC 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY ROUTE, 2018-2032 (USD MILLION)
TABLE 292. GCC 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 293. GCC 4-AA FOR CARBAPENEM ANTIBIOTIC MARKET SIZE, BY DISTRIBUTION CHANNEL,

Companies Mentioned

The key companies profiled in this 4-AA for Carbapenem Antibiotic market report include:
  • AstraZeneca plc
  • Asymchem Laboratories (Tianjin) Co., Ltd.
  • Aurobindo Pharma Ltd.
  • Daewoong Pharmaceutical Co., Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Eli Lilly and Company
  • Fresenius Kabi AG
  • Gland Pharma Limited
  • GlaxoSmithKline plc
  • Hikma Pharmaceuticals PLC
  • Lupin Limited
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sandoz AG
  • Shionogi & Co., Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.

Related Topics

Related Reports

Antibacterial Drugs - Global Strategic Business Report - Product Image

Antibacterial Drugs - Global Strategic Business Report

  • Report
  • 244 Pages
  • Global
From
EU - Antibiotics - Market Analysis, Forecast, Size, Trends and Insights - Product Image

EU - Antibiotics - Market Analysis, Forecast, Size, Trends and Insights

  • Report
  • Europe
From
Carbapenem-Based Antibiotics Market - Global Forecast 2025-2030 - Product Image

Carbapenem-Based Antibiotics Market - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Carbapenem-Based Antibiotics Market Report 2025 - Product Image

Carbapenem-Based Antibiotics Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Carbapenem-Based Antibiotics Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Carbapenem-Based Antibiotics Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.